Drug Discovery And Development
Cancer Research Technology (CRT) and SV Life Sciences have today announced the launch of Artios Pharma.
Scientists have shown that a drug combination slows cancer cell growth in a type of non-small cell lung cancer when tested in the lab.
Giving chemotherapy after radiotherapy delays further growth of a rare type of brain tumour, increasing the number of patients alive at five years.
The Cancer Research Technology (CRT) Pioneer Fund has today announced its investment in research to develop new drugs.
Cancer Research UK scientists have designed a computer model that applies techniques used to analyse social networks to identify new ways of treating cancer.
Scientists have shed more light on a vital cluster of proteins that helps cells – including cancer cells – to move around the body
Cancer Research UK and MedImmune launch ground-breaking biotherapeutics research centre in Cambridge
A new laboratory has been opened this week in Cambridge by life sciences minister George Freeman MP
BACIT is seeking shareholder approval to permit an investment into the CRT Pioneer Fund, taking the total to £70m.
Cancer Research UK is to increase investment by nearly 50 per cent over the next five years in its Centre for Drug Development.
A screening technology tags compounds with strands of DNA to assess prototype drugs for anti-cancer activity.